Nil Cosmoceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.73 M
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 0.32 M
About Nil Cosmoceuticals
Nil Cosmoceuticals Private Limited (NCPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 1999 and has a history of 25 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.73 M.
The company currently has active open charges totaling ₹0.32 M.
Mahendra Shah and Surekha Shah serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1999PTC122257
-
Company No.
122257
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Oct 1999
-
Date of AGM
30 Sep 2011
-
Date of Balance Sheet
31 Mar 2011
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nil Cosmoceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Shah
|
Director | 18-Oct-1999 | Current |
|
Surekha Shah
|
Director | 01-Feb-2005 | Current |
Financial Performance of Nil Cosmoceuticals.
Enhance accessibility to Nil Cosmoceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nil Cosmoceuticals?
Unlock access to Nil Cosmoceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Venus Drugs And Cosmetics LimitedMahendra Shah is a mutual person
Charges (Loans)
₹0.32 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2005 | Bank Of Maharashtra | ₹0.20 M | Open |
| 12 Mar 2001 | Bank Of Maharashtra | ₹0.12 M | Open |
How Many Employees Work at Nil Cosmoceuticals?
Unlock and access historical data on people associated with Nil Cosmoceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nil Cosmoceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nil Cosmoceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
